Follow us...

 

Search News Archives

Monthly Newsletter

 

Lab Bulletin May Newsletter

view the latest issue

Subscribe

News Channels

 

New Laboratory Products

 

Lab News

 

Microscopy & Image Analysis

 

Separation Science

 

Research & Case Studies

 

Literature

 

Videos

 

Events | Webinars

 

 

 

Conferences | Events

Gyros Protein Technologies and Fleet Bioprocessing Partner to Offer Assay Development and Transfer Services

publication date: Mar 14, 2018
 | 
author/source: Gyros Protein Technologies AB

Gyros-Protein-Technologies-Fleet-Bioprocessing-Partner-Offer-Assay-Development-Transfer-ServicesFleet to provide support for Gyrolab platform users in developing, transferring and optimizing assays

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and Fleet Bioprocessing Ltd. (Fleet), an expert provider of contract immunoassay development services and immunoassay reagent manufacture, announced today that they have signed a Certified Assay Transfer & Development Partner agreement, under which Fleet will provide assay development, transfer and optimization services for Gyrolab® platform users.

Gyrolab platforms offer great advantages over traditional assay formats by streamlining assay workflow to support rapid decision-making in drug development. Historically, accessing the resource internally to transfer assays from existing formats to work with the automated, nanoliter-scale Gyrolab® xP and Gyrolab xPlore™ immunoassay systems, has been challenging. Through this new partnership agreement, Gyrolab users worldwide can now easily access such services, either via Gyros Protein Technologies or by working directly with Fleet.

Fleet is an industry-leading expert in all aspects of immunoassay design, development and validation, with extensive know-how in immunoassay development for biotech, pharma and clinical diagnostic applications. Fleet has successfully executed assay development projects ranging from feasibility assessments to CE-marking studies, and is certified to ISO9001:2015 and ISO13485:2016, demonstrating robust and effective quality standards.

Mark Vossenaar, VP Sales EMEA, Gyros Protein Technologies, said: “This partnership was established in response to feedback from our customer base for the need to provide support in developing, transferring and optimizing assays onto the Gyrolab platform. We felt that an independent third-party specialist was best placed to provide this service, and we are confident we have chosen the ideal partner in Fleet Bioprocessing.”

Alastair Dent, Managing Director, Fleet Bioprocessing, said: “We are delighted to be working with Gyros Protein Technologies, and we are already seeing great interest in the new service, with our first project well under way and many more in the pipeline.”


more news from gyros



If you have not logged into the website then please enter your details below.



 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd

 


Promotions

 

Media Partners